How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
Geron Corp. is giving up some of its exclusive rights to develop and commercialize medical treatments derived from human embryonic stem cells. The agreement comes as part of the settlement of a lawsuit filed against Geron last year by the Wisconsin Alumni Research Foundation.
A University of Wisconsin scientist,...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
